
Immune Checkpoint Inhibitor Dose Reduction: Evidence for Equal Efficacy with Improved Safety and Cost Profiles
By Donnie Yance Immune checkpoint inhibitors (ICIs, also known as ICBs) have revolutionized cancer treatment by offering durable responses across multiple tumor types. However, these
